stockrow
Friday 6 November 2026
Export PNTG’s income statement to Excel — free account
The Pennant Group, Inc.
PNTG Healthcare Medical Care Facilities
The Pennant Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $947.7 million, up 36.3% from fiscal 2024.
- Revenue
- +32.0%
- EPS
- +55.6%
- Free cash flow
- −3.19%
- Total debt
- +662.8%
Quarter to September 2026, against a year earlier
36.58
3.42
−8.55%
Follow PNTG
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 From the 10-Q filed 4 Nov | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
32.36 | 34.25 | 39.31 | 37.50 |
P/S ratio |
1.03 | 1.03 | 1.17 | 1.16 | |
P/FCF ratio |
26.84 | 20.85 | 37.11 | 39.74 | |
P/Operating CF |
46.42 | (310.85) | 58.96 | 54.34 | |
P/B ratio |
2.60 | 2.72 | 3.18 | 3.25 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.19 | 1.20 | 1.33 | 1.32 | |
EV/EBITDA |
18.43 | 18.32 | 20.02 | 18.99 | |
EV/Operating CF |
23.39 | 18.50 | 27.57 | 23.95 | |
EV/FCF |
31.16 | 24.09 | 42.36 | 44.98 | |
Quick Ratio |
0.95 | 0.99 | 0.97 | 0.98 | |
Current Ratio |
1.14 | 1.19 | 1.20 | 1.18 | |
Net Debt/EBITDA |
7.81 | 8.15 | 8.85 | 8.78 | |
Debt/Assets |
17.96% | 17.74% | 19.04% | 19.02% | |
Debt/Equity |
0.46 | 0.44 | 0.49 | 0.47 | |
Asset Turnover |
1.15 | 1.20 | 1.23 | 1.31 | |
Operating CF/Net income |
2.43 | (0.40) | 2.40 | 2.61 | |
Capex/Depreciation |
(1.37) | (1.80) | (1.86) | (3.76) | |
Interest Coverage |
5.37 | 5.64 | 5.13 | 4.56 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
6.69% | 6.90% | 7.25% | 6.83% | |
Intangible Assets out of Total Assets |
0.45 | 0.46 | 0.42 | 0.42 | |
Share Based Compensation of Revenue |
0.75% | 0.88% | 0.99% | 1.10% | |
Graham Net Nets |
(0.44) | (0.39) | (0.35) | (0.33) | |
Graham Number |
14.56 | 14.99 | 15.67 | 16.75 | |
Earnings Yield |
3.09% | 2.92% | 2.54% | 2.67% | |
Free Cash Flow Yield |
3.73% | 4.80% | 2.69% | 2.52% | |
Revenue per Share |
8.37 | 8.22 | 8.55 | 8.64 | |
Operating CF per Share |
0.61 | (0.10) | 0.63 | 0.72 | |
Capex per Share |
(0.10) | (0.15) | (0.18) | (0.43) | |
Free Cash Flow per Share |
0.50 | (0.25) | 0.44 | 0.29 | |
Cash per Share |
0.49 | 0.14 | 0.44 | 0.53 | |
Shareholders Equity per Share |
10.83 | 11.21 | 11.61 | 11.99 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
10.83 | 11.21 | 11.61 | 11.99 | |
Free Cash Flow |
17.40 | (8.67) | 15.49 | 10.13 | |
Working Capital |
20.14 | 24.25 | 31.19 | 27.34 | |
Capital Expenditures |
(3.56) | (5.27) | (6.34) | (14.99) | |
Net Current Asset Value |
(426.52) | (414.22) | (449.26) | (443.98) | |
EV/EBIT |
21.77 | 21.64 | 23.63 | 22.57 | |
Capex to Sales |
0.01 | 0.02 | 0.02 | 0.05 | |
Price to Operating Income |
18.75 | 18.72 | 20.70 | 19.94 | |
| Other line items | |||||
Average Receivables |
102.21 | 108.91 | 114.45 | 113.46 | |
Average Payables |
21.95 | 20.80 | 22.73 | 24.58 | |
Average Assets |
823.85 | 850.05 | 894.35 | 898.23 | |
Average Common Equity |
343.11 | 356.23 | 369.03 | 381.40 |
Columns are period end dates · fundamentals updated 4 Nov 2026